« Previous
Next »
The Journal of Urology
Volume 168, Issue 6
, Pages 2483-2485
, December 2002
Transdermal Application of Verapamil Gel to the Penile Shaft Fails to Infiltrate the Tunica Albuginea
REFERENCES
- . The incidence of Peyronie's disease in Rochester Minnesota, 1950 through 1984 . J Urol . 1991;146:1007
-
.
Prevalence of Peyronie's disease: results of an 8, 000 man survey
.
J Urol
. 2000;163(suppl.):167;
abstract 742
-
.
Surgery of the penis and urethra. Peyronie's disease
.
In: 6th ed..
Walsh PC
, Retik AB
, Stamey TA
, Vaughan ED
editor.
Campbell's Urology
. vol. 3:
Philadelphia: W. B. Saunders Co.; 1992;p. 3011–3021
chapt. 83
- . Sexual dysfunction in Peyronie's disease: an analysis of 222 patients without previous local plaque therapy . J Urol . 1997;157:325
- . Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study . J Urol . 1993;149:56
-
.
The use of tocopherols in the treatment of Peyronie's disease
.
Ann NY Acad Sci
. 1949;52:390
- . Treatment of Peyronie's disease with potassium para-aminobenzoate (POTABA) . J Urol . 1953;81:770
- . The treatment of Peyronie's disease with tamoxifen . Br J Urol . 1992;70:648
- . Is colchicine effective in Peyronie's disease? A pilot study . Urology . 1994;44:291
- . A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease . J Androl . 1999;20:444
- . Peyronie's disease: results with dermo-jet injection of dexamethasone . J Urol . 1975;114:898
- . Treatment of Peyronie's disease with intralesional verapamil injection . J Urol . 1997;158:1395
- . Calcium antagonists retard extracellular matrix production in connective tissue equivalent . J Surg Res . 1990;49:463
-
.
Topical verapamil, trifluoperazine and magnesium sulfate for Peyronie's disease
.
Int J Impot Res
. 2001;13:S62
- . Proposal: trauma as the cause of the Peyronie's lesion . J Urol . 1997;157:285
- . The immunological features of Peyronie's disease . J Urol . 1996;155:159
- . Peyronie's disease is associated with an increase in transforming growth factor-β protein expression . J Urol . 1997;158:1391
- . Basic fibroblast growth factor expression in Peyronie's disease . J Urol . 2001;165:419
-
.
Peyronie's disease: cause and surgical treatment
.
AUA Today
. 1989;2:1
- . Isolation and characterization of collagen in Peyronie's disease . J Urol . 1989;141:629
- . New developments in topical estrogen therapy . Fertil Steril . 1997;67:1
- . Transdermal drug delivery . Dermatol Clin . 1998;16:289
- . Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures . J Pharm Sci . 1993;82:127
- . Iontophoresis for treatment of Peyronie's disease . J Urol . 2000;163:95
- . Transdermal electro motive multi-drug administration for Peyronie's disease: a randomized, double-blind, placebo-controlled, partial crossover study . J Urol . 1995;153(suppl.):472; abstract 973
PII: S0022-5347(05)64173-0
© 2002 American Urological Association, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
The Journal of Urology
Volume 168, Issue 6
, Pages 2483-2485
, December 2002

